| First Author | Kirschner LS | Year | 2010 |
| Journal | Mol Cell Endocrinol | Volume | 326 |
| Issue | 1-2 | Pages | 3-7 |
| PubMed ID | 20451576 | Mgi Jnum | J:163198 |
| Mgi Id | MGI:4821227 | Doi | 10.1016/j.mce.2010.04.027 |
| Citation | Kirschner LS (2010) PRKAR1A and the evolution of pituitary tumors. Mol Cell Endocrinol 326(1-2):3-7 |
| abstractText | Carney complex (CNC) is an inherited tumor predisposition associated with pituitary tumors, including GH-producing pituitary adenomas and rare reports of prolactinomas. This disease is caused by mutations in PRKAR1A, which encodes the type 1A regulatory subunit of the cAMP-dependent protein kinase, PKA. Loss of PRKAR1A causes enhanced PKA signaling, which leads to pituitary tumorigenesis. Mutations in the gene have not been detected in sporadic pituitary tumors, but there is some data to suggest that non-genomic mechanisms may cause loss of protein expression. Unlike CNC patients, mice heterozygous for Prkar1a mutations do not develop pituitary tumors, although complete knockout of the gene in the Pit1 lineage of the pituitary produces GH-secreting pituitary adenomas. These data indicate that complete loss of Prkar1a/PRKAR1A is able to cause pituitary tumors in mice and men. The pattern of tumors is likely related to the signaling pathways employed in specific pituitary cell types. |
